CURESEQ
CureSeq’s mission is to revolutionize next-generation sequencing in the oncology space by making it more affordable, offering faster time to results with a comprehensive solution. They offer products to advance your research endeavors, and will open their services shortly. Turnaround time using their products is 48 hours from extraction through generating clinically relevant mutations. CureSeq’s technology is born out of the Applied Genomics Thoracic Oncology Lab of Dr. Il-Jin Kim at UCSF.
CURESEQ
Industry:
Bioinformatics Biotechnology Genetics
Founded:
2014-01-01
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.cureseq.com
Total Employee:
11+
Status:
Closed
Contact:
4158595468
Email Addresses:
[email protected]
Total Funding:
700 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Font Awesome Nginx Amazon IPv6
Similar Organizations
ACT Genomics
ACT Genomics is a cancer molecular information service company teamed up with experts with multiple years’ experience in oncology
Neoprospecta
Neoprospecta uses high-throughput genomic sequencing and large scale bioinformatics.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Founder
Investors List
TSVC
TSVC investment in Venture Round - Cureseq
TSVC
TSVC investment in Seed Round - Cureseq
Venture Leader Group
Venture Leader Group investment in Seed Round - Cureseq
Official Site Inspections
http://www.cureseq.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
